• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童耐大环内酯类肺炎的病原体载量和大环内酯类耐药水平的临床意义

The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Pneumonia in Children.

作者信息

Leng Maodong, Xu Lu, Dong Zhen, Yang Junmei

机构信息

Department of Clinical Laboratory, Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, Henan, People's Republic of China.

Pediatric Internal Medicine Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, Henan, People's Republic of China.

出版信息

J Inflamm Res. 2024 Oct 15;17:7339-7346. doi: 10.2147/JIR.S491981. eCollection 2024.

DOI:10.2147/JIR.S491981
PMID:39429852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11490243/
Abstract

OBJECTIVE

() pneumonia presses a serious threat on children's health. This study was aimed to investigate the clinical significance of pathogen loads and macrolide resistance levels for macrolide-resistant (MRMP)-induced pneumonia in children.

METHODS

Serum levels of inflammatory markers including lactic dehydrogenase (LDH), D-dimer, C-reactive protein (CRP) were tested. RT‒PCR was used for the detection of and the macrolide resistance levels. The patients were classified into high pathogen load and low pathogen load groups based on the Ct values of the gene, and high macrolide resistance level and low macrolide resistance level groups based on the relative levels of macrolide resistance associated mutations to that of the gene. The rates of alternative antibiotic use and hospitalization days were recorded, and the leukocyte counts were tested.

RESULTS

The rates of elevated inflammatory markers from high to low were LDH, CRP and D-dimer. The Ct values of the gene ranged from 19 to 35, and patients with higher pathogen loads had greater rates of alternative antibiotic use; higher levels of LDH, D-dimer, CRP and neutrophil counts (NEUT); and longer hospitalization durations. The range of the macrolide resistance levels was 0.31-2.11, and the rates of alternative antibiotic use, NEUT, CRP and D-dimer levels were higher in patients with higher macrolide resistance levels.

CONCLUSION

LDH was a more frequently elevated serum inflammatory marker than D-dimer and CRP, and the pathogen load and macrolide resistance levels possessed important clinical significance for MRMP-induced pneumonia in children.

摘要

目的

()肺炎严重威胁儿童健康。本研究旨在探讨病原体载量和大环内酯类耐药水平对儿童大环内酯类耐药(MRMP)所致肺炎的临床意义。

方法

检测血清中乳酸脱氢酶(LDH)、D-二聚体、C反应蛋白(CRP)等炎症标志物水平。采用RT-PCR检测(原文此处信息不完整)及大环内酯类耐药水平。根据(原文此处基因名称不完整)基因的Ct值将患者分为高病原体载量组和低病原体载量组,根据大环内酯类耐药相关突变与(原文此处基因名称不完整)基因的相对水平分为高大环内酯类耐药水平组和低大环内酯类耐药水平组。记录替代抗生素使用比例和住院天数,并检测白细胞计数。

结果

炎症标志物升高比例从高到低依次为LDH、CRP和D-二聚体。(原文此处基因名称不完整)基因的Ct值范围为19至35,病原体载量较高的患者替代抗生素使用率更高;LDH、D-二聚体、CRP和中性粒细胞计数(NEUT)水平更高;住院时间更长。大环内酯类耐药水平范围为0.31 - 2.11,大环内酯类耐药水平较高的患者替代抗生素使用率、NEUT、CRP和D-二聚体水平更高。

结论

LDH是比D-二聚体和CRP更常升高的血清炎症标志物,病原体载量和大环内酯类耐药水平对儿童MRMP所致肺炎具有重要临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/11490243/984cca64ceb7/JIR-17-7339-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/11490243/984cca64ceb7/JIR-17-7339-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/11490243/984cca64ceb7/JIR-17-7339-g0001.jpg

相似文献

1
The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Pneumonia in Children.儿童耐大环内酯类肺炎的病原体载量和大环内酯类耐药水平的临床意义
J Inflamm Res. 2024 Oct 15;17:7339-7346. doi: 10.2147/JIR.S491981. eCollection 2024.
2
Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.儿童大环内酯类耐药肺炎支原体肺炎诊断与治疗专家共识。
World J Pediatr. 2024 Sep;20(9):901-914. doi: 10.1007/s12519-024-00831-0. Epub 2024 Aug 14.
3
The clinical significance of macrolide resistance in pediatric infection during COVID-19 pandemic.儿童感染大环内酯类耐药在 COVID-19 大流行期间的临床意义。
Front Cell Infect Microbiol. 2023 May 12;13:1181402. doi: 10.3389/fcimb.2023.1181402. eCollection 2023.
4
Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia.评估肺炎支原体肺炎患儿住院时间延长的相关变量。
Clin Respir J. 2022 Nov;16(11):756-767. doi: 10.1111/crj.13549. Epub 2022 Oct 7.
5
Clinical Characteristics of Macrolide-Refractory Pneumonia in Korean Children: A Multicenter Retrospective Study.韩国儿童大环内酯类难治性肺炎的临床特征:一项多中心回顾性研究
J Clin Med. 2022 Jan 8;11(2):306. doi: 10.3390/jcm11020306.
6
Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.C反应蛋白对大环内酯类耐药肺炎支原体肺炎患儿大环内酯类药物治疗反应的预测价值
Korean J Pediatr. 2014 Apr;57(4):186-92. doi: 10.3345/kjp.2014.57.4.186. Epub 2014 Apr 30.
7
Prevalence and clinical manifestations of macrolide resistant pneumonia in Korean children.韩国儿童中对大环内酯类耐药肺炎的患病率及临床表现
Korean J Pediatr. 2017 May;60(5):151-157. doi: 10.3345/kjp.2017.60.5.151. Epub 2017 May 31.
8
Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.观察性回顾性临床研究:中国儿科病例中大环内酯类耐药肺炎支原体肺炎的临床特征。
Sci Rep. 2024 Mar 7;14(1):5632. doi: 10.1038/s41598-024-55311-2.
9
Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.美国俄亥俄州儿童的大环内酯类耐药肺炎支原体感染
Emerg Infect Dis. 2021 Jun;27(6):1588-1597. doi: 10.3201/eid2706.203206.
10
D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.D-二聚体:儿童重症支原体肺炎的危险因素
Front Pediatr. 2022 Apr 12;10:828437. doi: 10.3389/fped.2022.828437. eCollection 2022.

本文引用的文献

1
Correlation of DNA load, genotyping, and clinical phenotype of infection in children.儿童感染的DNA载量、基因分型与临床表型的相关性
Front Pediatr. 2024 Apr 9;12:1369431. doi: 10.3389/fped.2024.1369431. eCollection 2024.
2
Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.观察性回顾性临床研究:中国儿科病例中大环内酯类耐药肺炎支原体肺炎的临床特征。
Sci Rep. 2024 Mar 7;14(1):5632. doi: 10.1038/s41598-024-55311-2.
3
Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children.
儿童肺炎支原体肺炎致塑性支气管炎的临床特征及危险因素。
BMC Pulm Med. 2023 Nov 23;23(1):468. doi: 10.1186/s12890-023-02766-0.
4
Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia.分析肺炎支原体肺炎患儿支气管肺泡灌洗液中细胞因子水平、细胞学发现和 MP-DNA 水平。
Immun Inflamm Dis. 2023 May;11(5):e849. doi: 10.1002/iid3.849.
5
Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.儿童社区获得性肺炎支原体的临床特征和血清炎症标志物。
Clin Respir J. 2023 Jul;17(7):607-617. doi: 10.1111/crj.13620. Epub 2023 May 4.
6
The molecular characteristics, diagnosis, and treatment of macrolide-resistant in children.儿童大环内酯类耐药的分子特征、诊断与治疗
Front Pediatr. 2023 Mar 2;11:1115009. doi: 10.3389/fped.2023.1115009. eCollection 2023.
7
High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.抗 MDA5 抗体阳性皮肌炎患者中肺孢子菌肺炎的高患病率和高死亡率。
Rheumatology (Oxford). 2023 Oct 3;62(10):3302-3309. doi: 10.1093/rheumatology/kead063.
8
Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia.肺炎支原体耐药性与儿童难治性肺炎支原体肺炎支气管肺泡灌洗液临床特征的相关性。
Ital J Pediatr. 2022 Nov 26;48(1):190. doi: 10.1186/s13052-022-01376-6.
9
D-dimer as a predictive and prognostic marker among COVID-19 patients.D-二聚体作为 COVID-19 患者的预测和预后标志物。
Saudi Med J. 2022 Jul;43(7):723-729. doi: 10.15537/smj.2022.43.7.20220213.
10
Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis.大环内酯类耐药的全球流行率:系统评价和荟萃分析。
J Antimicrob Chemother. 2022 Aug 25;77(9):2353-2363. doi: 10.1093/jac/dkac170.